This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Jan 30;387(10017):405-6.

doi: 10.1016/S0140-6736(15)00816-8. Epub 2015 Nov 7.

Lower blood pressure targets: to whom do they apply?

Mattias Brunström¹, Bo Carlberg²

Affiliations

Affiliations

¹ Department of Public Health and Clinical Medicine, Division of Medicine, Umeå University, SE-901 85 Umeå, Sweden.
² Department of Public Health and Clinical Medicine, Division of Medicine, Umeå University, SE-901 85 Umeå, Sweden. Electronic address: bo.carlberg@umu.se.

PMID: 26559745
DOI: 10.1016/S0140-6736(15)00816-8

Comment

Lower blood pressure targets: to whom do they apply?

Mattias Brunström et al. Lancet. 2016.

. 2016 Jan 30;387(10017):405-6.

doi: 10.1016/S0140-6736(15)00816-8. Epub 2015 Nov 7.

Authors

Mattias Brunström¹, Bo Carlberg²

Affiliations

¹ Department of Public Health and Clinical Medicine, Division of Medicine, Umeå University, SE-901 85 Umeå, Sweden.
² Department of Public Health and Clinical Medicine, Division of Medicine, Umeå University, SE-901 85 Umeå, Sweden. Electronic address: bo.carlberg@umu.se.

PMID: 26559745
DOI: 10.1016/S0140-6736(15)00816-8

No abstract available

PubMed Disclaimer

Comment on

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahimi K, Perkovic V, Rodgers A. Xie X, et al. Lancet. 2016 Jan 30;387(10017):435-43. doi: 10.1016/S0140-6736(15)00805-3. Epub 2015 Nov 7. Lancet. 2016. PMID: 26559744

Similar articles

Intensive blood pressure lowering.
Sonoda Y, Higuchi A, Morita T, Mori J, Shimmura H. Sonoda Y, et al. Lancet. 2016 Jun 4;387(10035):2291. doi: 10.1016/S0140-6736(16)30688-2. Lancet. 2016. PMID: 27302267 No abstract available.
Intensive blood pressure lowering - Authors' reply.
Xie X, Atkins E, Lv J, Rodgers A. Xie X, et al. Lancet. 2016 Jun 4;387(10035):2291. doi: 10.1016/S0140-6736(16)30366-X. Lancet. 2016. PMID: 27302266 No abstract available.
ACP Journal Club. Review: More- vs less-intensive BP-lowering regimens reduce major CV events.
Chatterjee S, Sardar P, Chakraborty A, Chatterjee S. Chatterjee S, et al. Ann Intern Med. 2016 Feb 16;164(4):JC14. doi: 10.7326/ACPJC-2016-164-4-014. Ann Intern Med. 2016. PMID: 26882299 No abstract available.
[Blood pressure targets for antihypertensive treatment - Consent with ongoing discussion].
Holzgreve H. Holzgreve H. MMW Fortschr Med. 2016 Dec;158(21-22):85-91. doi: 10.1007/s15006-016-9112-1. MMW Fortschr Med. 2016. PMID: 27966120 Review. German. No abstract available.
Influencing the natural history of hypertension: it is the blood pressure achieved more than the drug.
Fagard RH. Fagard RH. J Hypertens. 2008 Aug;26(8):1533-5. doi: 10.1097/HJH.0b013e32830508be. J Hypertens. 2008. PMID: 18622225 Review. No abstract available.

See all similar articles

Cited by

Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
Saiz LC, Gorricho J, Garjón J, Celaya MC, Erviti J, Leache L. Saiz LC, et al. Cochrane Database Syst Rev. 2020 Sep 9;9(9):CD010315. doi: 10.1002/14651858.CD010315.pub4. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2022 Nov 18;11:CD010315. doi: 10.1002/14651858.CD010315.pub5. PMID: 32905623 Free PMC article. Updated.
Predicting Risk of Type 2 Diabetes by Using Data on Easy-to-Measure Risk Factors.
Turi KN, Buchner DM, Grigsby-Toussaint DS. Turi KN, et al. Prev Chronic Dis. 2017 Mar 9;14:E23. doi: 10.5888/pcd14.160244. Prev Chronic Dis. 2017. PMID: 28278129 Free PMC article.
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
Saiz LC, Gorricho J, Garjón J, Celaya MC, Erviti J, Leache L. Saiz LC, et al. Cochrane Database Syst Rev. 2018 Jul 20;7(7):CD010315. doi: 10.1002/14651858.CD010315.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2020 Sep 9;9:CD010315. doi: 10.1002/14651858.CD010315.pub4. PMID: 30027631 Free PMC article. Updated.
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
Saiz LC, Gorricho J, Garjón J, Celaya MC, Erviti J, Leache L. Saiz LC, et al. Cochrane Database Syst Rev. 2022 Nov 18;11(11):CD010315. doi: 10.1002/14651858.CD010315.pub5. Cochrane Database Syst Rev. 2022. PMID: 36398903 Free PMC article.
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
Saiz LC, Gorricho J, Garjón J, Celaya MC, Muruzábal L, Malón MDM, Montoya R, López A. Saiz LC, et al. Cochrane Database Syst Rev. 2017 Oct 11;10(10):CD010315. doi: 10.1002/14651858.CD010315.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2018 Jul 20;7:CD010315. doi: 10.1002/14651858.CD010315.pub3. PMID: 29020435 Free PMC article. Updated.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information